Abbott Laboratories (ABT)

75.77
0.20 0.26
NYSE : Health Technology
Prev Close 75.97
Open 75.60
Day Low/High 75.20 / 75.96
52 Wk Low/High 60.32 / 80.74
Volume 4.42M
Avg Volume 5.56M
Exchange NYSE
Shares Outstanding 1.76B
Market Cap 135.14B
EPS 1.30
P/E Ratio 52.11
Div & Yield 1.28 (1.57%)

Latest News

Arena Pharmaceuticals, DaVita, Merck: 'Mad Money' Lightning Round

Arena Pharmaceuticals, DaVita, Merck: 'Mad Money' Lightning Round

Jim Cramer weighs in on Arena Pharmaceuticals, DaVita, Merck, Abbott Laboratories, IAC Interactive, Yext and more.

Weekly Roundup

Markets' rocky week ends up close to where it began.

Jim Cramer: These 7 True Laggards Have Caught Fire

Jim Cramer: These 7 True Laggards Have Caught Fire

These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.

Nearly 9 Out Of 10 College Students With Student Debt Say It's Important To Find A Company That Offers Loan Relief

Nearly 9 Out Of 10 College Students With Student Debt Say It's Important To Find A Company That Offers Loan Relief

- The YouGov-Abbott Student Loan Impact Survey shows 87% of those in college or graduating this year with student debt say finding a company with a student loan benefit is important to them

Abbott Partners With NIH On BRAIN Initiative To Advance Research For Neurological Disorders

Abbott Partners With NIH On BRAIN Initiative To Advance Research For Neurological Disorders

- Partnership with NIH aims to increase understanding and accelerate the application of neurostimulation therapies

Weekly Roundup

Markets face rocky week as trade wars flare up and talks appear to falter.

Sitting Tight, but We Have the Cash

Now that our cash levels are even more flushed than before, we believe we have prudently acted for the uncertainty we face this week.

Continuing Our Cash-Raising Efforts

There is room here to take even more off the table and lock in some of the big gains.

Abbott To Present At UBS Global Healthcare Conference

Abbott To Present At UBS Global Healthcare Conference

ABBOTT PARK, Ill., May 7, 2019 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the UBS Global Healthcare Conference on Tuesday, May 21, 2019.

Abbott Launches Next-generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

Abbott Launches Next-generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

WORLD'S FIRST SMARTPHONE-COMPATIBLE IMPLANTABLE HEART MONITOR, ABBOTT'S CONFIRM Rx™ ICM OFFERS MORE ACCURATE DETECTION OF HEART RHYTHM DISORDERS

Abbott Receives WHO Prequalification Approval For Breakthrough HIV Point-of-Care Test

Abbott Receives WHO Prequalification Approval For Breakthrough HIV Point-of-Care Test

- WHO Prequalification approval allows Abbott to bring critical technology to more resource-limited settings

Abbott, The U.S. Department Of Defense And TRACK-TBI Partner To Study Point-of-Care Blood Test For Concussions

Abbott, The U.S. Department Of Defense And TRACK-TBI Partner To Study Point-of-Care Blood Test For Concussions

-- Academic, military and healthcare leaders have come together to conduct a scientifically rigorous clinical trial of a blood test in development for the brain

New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease

New Study Finds Abbott Blood Test Can Help Predict Future Cardiac Events In Adults With No Known Heart Disease

- Research found Abbott's High-Sensitive Troponin-I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors

Weekly Roundup

Heavy earnings week and strong GDP push stocks higher.

Last Week's Portfolio Changes

We exited one position for a large gain and downgraded four others last week.

Weekly Roundup

Markets see flat trading for first week of earnings season.

Stocks Fall as Declines in IBM and UnitedHealth Pull the Dow Lower

Stocks Fall as Declines in IBM and UnitedHealth Pull the Dow Lower

The Dow Jones Industrial Average finishes slightly down on sharp declines in shares of IBM and UnitedHealth.

Exiting Our Danaher Position for a Big Gain

We are ringing the register this afternoon and declaring victory on DHR ahead of earnings.

Video: Jim's Daily Rundown for Wednesday

Jim discusses Abbott Laboratories' earnings release, his view of the Apple-Qualcomm settlement as it relates to the 5G cycle, several upcoming earnings reports, Anadarko Petroleum, UnitedHealth and much more!

Jim Cramer's Takeaway From Abbott's Earnings

Jim Cramer's Takeaway From Abbott's Earnings

Jim Cramer breaks down what he was watching when Abbott reported earnings Wednesday morning.

Abbott Labs Tops Expectations With First-Quarter Results

This was a very good quarter and the stock performance today is more of a reflection of the hatred for anything healthcare related as well as ABT's already premium valuation.

Abbott Laboratories Reports Healthy First-Quarter Profit

Abbott Laboratories Reports Healthy First-Quarter Profit

Abbott reports earnings above its own guidance and that of Wall Street analysts.

Jim Cramer's Thoughts on Abbott and Netflix Earnings, Qualcomm and Apple

Jim Cramer's Thoughts on Abbott and Netflix Earnings, Qualcomm and Apple

Qualcomm and Apple have settled their disputes, and Abbott and Netflix both released earnings.

Jim Cramer Breaks Down Qualcomm, Netflix, and Abbott

Jim Cramer Breaks Down Qualcomm, Netflix, and Abbott

Jim Cramer weighs in on Abbott's earnings, Qualcomm's dispute with Apple is over and Netflix's earnings.

Abbott Reports First-Quarter 2019 Results

Abbott Reports First-Quarter 2019 Results

- Sales and EPS growth exceed guidance; projects strong full-year outlook

Good News From China, Plus Netflix Earnings and Playing CSX: Market Recon

Good News From China, Plus Netflix Earnings and Playing CSX: Market Recon

China reported positive data, bolstering markets. Netflix had a beat on earnings, but faces fierce competition ahead. CSX is a thing of beauty.

Qualcomm and Apple, Sprint and T-Mobile, Netflix - 5 Things You Must Know

Qualcomm and Apple, Sprint and T-Mobile, Netflix - 5 Things You Must Know

U.S. stock futures rise Wednesday, following on from Tuesday's gains that were spurred on by generally solid earnings reports; Qualcomm surges after the chipmaker ends its long-running dispute with Apple; Netflix's second-quarter forecast disappoints Wall Street; Sprint and T-Mobile slide after a report says their proposed merger is getting resistance form the Justice Department.

WATCH: Buy Stocks in Companies That Run Their Earnings Calls Well, Says Cramer

WATCH: Buy Stocks in Companies That Run Their Earnings Calls Well, Says Cramer

They usually run their businesses well, too, Cramer says in revealing his '5 Rules for Trading Stocks During Earnings Season.'

TheStreet Quant Rating: B (Buy)